Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-21-014861

Chief Accounting Officer sold 25,000 shares at $23.88 ($597,030)

  • Chief Accounting Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lyon Joseph Douglas Chief Accounting Officer 2021-04-01 Option exercise +25,000 $11.35 $283,750 25,000 D
Lyon Joseph Douglas Chief Accounting Officer 2021-04-01 Sale −25,000 $23.88 $597,030 0 D
Derivatives
Lyon Joseph Douglas Chief Accounting Officer 2021-04-01 Option exercise · Stock Option (Right to Buy) −25,000 75,000 D
Open-market sales · 25,000 sh · avg $23.88 · $597,030
Loading xslF345X03/doc4.xml…